Article Details
Retrieved on: 2023-01-11 07:07:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under the terms of the agreement, AstraZeneca will initiate a tender offer to acquire all of CinCor's outstanding shares for a price of $26 per share ...
Article found on: www.domain-b.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here